Material delivery system

a material delivery and material technology, applied in balloon catheters, medical science, surgery, etc., can solve the problems of rhinitis, nausea, weight loss and lethargy, and the wall of the artery is re-inserted into the lumen, and achieves the effect of relieving rhinitis

Inactive Publication Date: 2006-08-24
BY PASS
View PDF57 Cites 327 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0022] In an exemplary embodiment of the invention, the cytotoxic agent contains a chemotherapeutic agent and injection of the agent directly into one or more tumors spares adjacent and / or remote normal tissue from a toxic effect of the chemotherapeutic agent.
[0023] In an exemplary embodiment of the invention, the balloon delivers a medicament to cells covered by mucosa. Optionally, the cells are located in a nostril or nasal sinus. Optionally, the cells are located in a genitourinary tract (e.g. vagina, cervix, uterus, bladder or urethra). In an exemplary embodiment of the invention, the medicament is delivered to nostrils and / or nasal sinuses to provide relief from rhinitis.

Problems solved by technology

One problem with this method is restenosis, in which the artery responds to the PTCA procedure by inflammation and inward growth.
Another problem is collapse of the wall of the artery back into its lumen.
Some problems have been reported with these methods, for example, thrombosis formation.
Systemic administration of these compounds causes undesirable side effects such as nausea, hair loss, appetite suppression, weight loss and lethargy.
In additional clinical scenarios, a mucosal layer covering cells lining a lumen reduces a potential efficacy of “washing”.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Material delivery system
  • Material delivery system
  • Material delivery system

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

Overview

[0182]FIG. 1 shows a flowchart of a method and FIGS. 2A-2E illustrate the acts of the method, of applying material(s) to and / or driving material(s) into the walls of a blood vessel, in accordance with an exemplary embodiment of the invention. FIGS. 2A-2E are discussed in parallel with the description of FIG. 1. Variations on the devices and / or methods are described following.

Exemplary Method

[0183]FIG. 1 is a flowchart 100 of a method of treating blood vessels, in accordance with an exemplary embodiment of the invention.

[0184] At 102, a narrowing or other problem in a wall 204 of a blood vessel 200 (FIG. 2A) is identified. Optionally, the narrowing is a plaque deposit 206, for example, a deposit with a calcified filling 202.

[0185] At 104, a catheter treatment system 210 (FIG. 2B) is inserted into the body and guided to the narrowing. Optionally, system 210 is used also to identify the problem, for example, including a contrast material port (not shown) or an imager (no...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A method for injecting a therapeutic agent into a target tissue, the method comprising: (a) providing an expandable member; (b) positioning said expandable member in proximity to the target tissue; (c) Introducing the therapeutic agent into the expandable member until a desired pressure is achieved; and (d) creating a plurality of small apertures in the expandable member.

Description

RELATED APPLICATIONS [0001] The present application is a continuation in part of PCT application IL / 2005 / 000749 filed on Jul. 14, 2005 which claims the benefit under 119(e) of 60 / 587,335 filed Jul. 14, 2004, 60 / 599,884 filed Aug. 10, 2004, 60 / 603,262 filed Aug. 23, 2004 and 60 / 675,477 filed Apr. 28, 2005, an inventor common to all of these applications is Mordechay Beyar, the disclosures of which are incorporated herein by reference.FIELD OF THE INVENTION [0002] The present invention relates to the delivery of materials, for example, high speed intrabody needle-less injection. BACKGROUND OF THE INVENTION [0003] A common treatment for a blocked artery, especially a coronary artery, is PTCA, in which a balloon is inflated inside the lumen of the artery, causing the lumen to increase, while compressing the blockage and / or forcefully expanding the artery. One problem with this method is restenosis, in which the artery responds to the PTCA procedure by inflammation and inward growth. Ano...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61M29/00A61F2/958
CPCA61F2/958A61M25/10A61M25/1027A61M2025/105A61M2025/1088A61B2018/00023A61B2018/00029A61B2018/00238A61B2018/00345A61B2018/00642A61B2018/0066A61B2018/00672A61B2018/00678A61B2018/00708A61B2018/00744A61B2018/00863A61B2018/2211A61B2018/266
Inventor BEYAR, MORDECHAYGLOBERMAN, ORENKELLER, RAMI
Owner BY PASS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products